Similarly in NSCLC patients, Tpex cells, expressing low coinhibitory molecules (CD39- TIM-3- LAYN-) and high level of GZMK, increase in responsive tumors after treatment (50). This evidence concerns the gene HAVCR2 and non-small cell lung carcinoma.